159 related articles for article (PubMed ID: 15562414)
1. Selective loss of regulatory T cells in thymomas.
Ströbel P; Rosenwald A; Beyersdorf N; Kerkau T; Elert O; Murumägi A; Sillanpää N; Peterson P; Hummel V; Rieckmann P; Burek C; Schalke B; Nix W; Kiefer R; Müller-Hermelink HK; Marx A
Ann Neurol; 2004 Dec; 56(6):901-4. PubMed ID: 15562414
[TBL] [Abstract][Full Text] [Related]
2. Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma.
Luther C; Poeschel S; Varga M; Melms A; Tolosa E
J Neuroimmunol; 2005 Jul; 164(1-2):124-8. PubMed ID: 15923045
[TBL] [Abstract][Full Text] [Related]
3. Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas.
Nenninger R; Schultz A; Hoffacker V; Helmreich M; Wilisch A; Vandekerckhove B; Hünig T; Schalke B; Schneider C; Tzartos S; Kalbacher H; Müller-Hermelink HK; Marx A
Lab Invest; 1998 Jun; 78(6):743-53. PubMed ID: 9645765
[TBL] [Abstract][Full Text] [Related]
4. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
[TBL] [Abstract][Full Text] [Related]
5. [Histological studies of thymomas from 17 myasthenia gravis and 1 pure red cell aplasia patients and the T cell subsets before and after in vitro culture with rIL-2].
Takiguchi T
Arerugi; 1993 May; 42(5):665-75. PubMed ID: 8323466
[TBL] [Abstract][Full Text] [Related]
6. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.
Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A
Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864
[TBL] [Abstract][Full Text] [Related]
7. [Immunophenotypic and genotypic characterization of T-cell populations in thymomas].
Scherrer CC; Knecht H; Wiesli M; Dirsch OR; Odermatt B; Heitz PU
Verh Dtsch Ges Pathol; 1990; 74():350-3. PubMed ID: 1708611
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.
Kraus VB; Harden EA; Wittels B; Moore JO; Haynes BF
Am J Pathol; 1988 Sep; 132(3):552-62. PubMed ID: 3261946
[TBL] [Abstract][Full Text] [Related]
9. Cortical thymocyte differentiation in thymomas: an immunohistologic analysis of the pathologic microenvironment.
Takacs L; Savino W; Monostori E; Ando I; Bach JF; Dardenne M
J Immunol; 1987 Feb; 138(3):687-98. PubMed ID: 2433328
[TBL] [Abstract][Full Text] [Related]
10. Micronodular thymoma: an epithelial tumour with abnormal chemokine expression setting the stage for lymphoma development.
Ströbel P; Marino M; Feuchtenberger M; Rouzière AS; Tony HP; Wulbrand U; Förster R; Zettl A; Lee Harris N; Kreipe H; Laeng RH; Müller-Hermelink HK; Marx A
J Pathol; 2005 Sep; 207(1):72-82. PubMed ID: 15965907
[TBL] [Abstract][Full Text] [Related]
11. A CTLA4high genotype is associated with myasthenia gravis in thymoma patients.
Chuang WY; Ströbel P; Gold R; Nix W; Schalke B; Kiefer R; Opitz A; Klinker E; Müller-Hermelink HK; Marx A
Ann Neurol; 2005 Oct; 58(4):644-8. PubMed ID: 16178018
[TBL] [Abstract][Full Text] [Related]
12. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
[TBL] [Abstract][Full Text] [Related]
13. Immunohistology of human thymomas.
Kornstein MJ; Hoxie JA; Levinson AI; Brooks JJ
Arch Pathol Lab Med; 1985 May; 109(5):460-3. PubMed ID: 2580505
[TBL] [Abstract][Full Text] [Related]
14. Corpuscular thymoma: entity or variant of organotypical thymomas WHO B2/B3?
Laeng RH; Eimoto T; Kuo TT; Zettl A; Marx A; Moschopulos M; Tateyama H; Shimokawa K
Pathol Res Pract; 2006; 202(10):697-704. PubMed ID: 16887284
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological study of thymomas--correlation of histologic subtype to myasthenia gravis and prognosis.
Sundaram C; Rajagopal P; Rakshak AD; Omprakash G; Das SM; Murthy JM
Indian J Pathol Microbiol; 2003 Jul; 46(3):378-81. PubMed ID: 15025278
[TBL] [Abstract][Full Text] [Related]
16. Patients with thymomas have an increased risk of developing additional malignancies: lack of immunological surveillance?
Granato F; Ambrosio MR; Spina D; Lazzi S; Rocca BJ; Voltolini L; Bongiolatti S; Luzzi L; Gotti G; Leoncini L; Tosi P
Histopathology; 2012 Feb; 60(3):437-42. PubMed ID: 22276606
[TBL] [Abstract][Full Text] [Related]
17. [Distribution of B-lymphocyte subgroup CD20 and its clinical significance in patients with myasthenia gravis].
Zhang Q; Hu Y; Zhang L; Li Y; Yin H; Li J
Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):239-41. PubMed ID: 11825378
[TBL] [Abstract][Full Text] [Related]
18. Thymoma: a pathological study of 50 cases.
Vaideeswar P; Padmanabhan A; Deshpande JR; Pandit SP
J Postgrad Med; 2004; 50(2):94-7. PubMed ID: 15235201
[TBL] [Abstract][Full Text] [Related]
19. Glia maturation factor-beta is produced by thymoma and may promote intratumoral T-cell differentiation.
Yamazaki H; Tateyama H; Asai K; Fukai I; Fujii Y; Tada T; Eimoto T
Histopathology; 2005 Sep; 47(3):292-302. PubMed ID: 16115230
[TBL] [Abstract][Full Text] [Related]
20. Increased mast cell density and microvessel density in the thymus of patients with myasthenia gravis.
Raica M; Cîmpean AM; Encică S; Scridon T; Bârsan M
Rom J Morphol Embryol; 2007; 48(1):11-6. PubMed ID: 17502945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
